We’ve spent the past few months talking a lot about some of the psychedelic medicines that may be FDA approved soon, but this month we turn our attention to the one psychedelic medicine available now: ketamine.
Clinicians are likely familiar with ketamine as an anesthetic, but may not know about its uses in mental health. Beyond that, many questions arise such as which form of ketamine to recommend for which patient, what should one look for in selecting a ketamine center, and how can we ensure better access to this powerful medicine?
To answer those questions, we are honored to have two panelists on this month’s webinar to cover:
- What ketamine is
- How it works
- What conditions it can treat
- The many forms in which it comes
- Ketamine-assisted therapy
- Ketamine best practices
- Increasing access to ketamine
As always, there will be ample time for audience Q & A, so you’ll get to interact with the panelists directly!
So please join us for this live panel discussion on Thursday, September 30th at 5 pm Pacific, 8 pm Eastern. This is exclusively for members of the Psychedelic Medicine Association, so if you have not yet registered, please do so here. And for members, please register for the panel here. A link to the recording will be available afterward if you cannot make it to the live event.
Hope to see you all on the 30th!


